Skip to main content

Day: April 28, 2025

UAB “Atsinaujinančios energetikos investicijos” aims to extend the Company’s operational term and to adopt a decision regarding the approval of the terms for a planned new bond program with a nominal value of up to €100 million

The management company UAB “LORDS LB ASSET MANAGEMENT” (hereinafter referred to as the Management Company) has decided to convene an extraordinary general meeting of shareholders of UAB “Atsinaujinančios energetikos investicijos”, the closed-end investment company intended for informed investors (hereinafter referred to as the Company) on May 16, 2025. At the meeting, it is proposed to make a decision to extend the Company’s operational term by 2 years and to adopt a decision on the approval of a planned new bond program of fixed annual interest rate of 5-10% for a term of up to 2.5 years, provided that market conditions are favorable. This announcement does not constitute an invitation to sell or offer securities or investments, nor does it constitute an invitation to purchase securities or investments in...

Continue reading

Portage Biotech Reports Confirmatory Preclinical Results in Mesothelioma Supporting First-In-Human Trial of PORT-7

DOVER, Del., April 28, 2025 (GLOBE NEWSWIRE) — Portage Biotech Inc. (NASDAQ: PRTG), a clinical-stage immuno-oncology company today reports confirmatory preclinical efficacy data for PORT-7 (TT-4), a selective adenosine A2B receptor inhibitor. Dr. Luciano Mutti of the Department of Applied Clinical Sciences and Biotechnology at the University of L’Aquila, Italy, an internationally recognized expert in mesothelioma, will be presenting the data at the American Association for Cancer Research® (AACR) Annual Meeting at the McCormick Place Convention Center in Chicago, Illinois on April 28, 2025. The new data in a murine mesothelioma model demonstrated single agent activity for PORT-7 that was superior to treatment with single agent anti-PD1 antibody. Moreover, the combination of PORT-7 and anti-PD1 was superior to treatment with...

Continue reading

Provident Financial Holdings Reports Third Quarter of Fiscal Year 2025 Results

Net Income of $1.86 million in the March 2025 Quarter, Up 113% from the Sequential Quarter and Up 24% from the Comparable Quarter Last Year Net Interest Margin of 3.02% in the March 2025 Quarter, Up 11 Basis Points from the Sequential Quarter and 28 Basis Points from the Comparable Quarter Last Year Loans Held for Investment of $1.06 Billion at March 31, 2025, Up 1% from June 30, 2024 Total Deposits of $901.3 Million at March 31, 2025, Up 2% from June 30, 2024 Non-Performing Assets to Total Assets Ratio of 0.11% at March 31, 2025, Down from 0.20% at June 30, 2024 RIVERSIDE, Calif., April 28, 2025 (GLOBE NEWSWIRE) — Provident Financial Holdings, Inc. (“Company”), NASDAQ GS: PROV, the holding company for Provident Savings Bank, F.S.B. (“Bank”), today announced earnings for the third quarter of the fiscal year ending June 30, 2025. The...

Continue reading

Liberty Gold Announces the Retirement of Cal Everett, CEO & Director and the Appointment of Dr. Jon Gilligan as new President and Chief Executive

Cal Everett to guide the Liberty Gold spin-out of Specialty American Metals as future non-executive Director and build a second Liberty Gold controlled company VANCOUVER, British Columbia, April 28, 2025 (GLOBE NEWSWIRE) — Liberty Gold Corp. (TSX:LGD; OTCQX:LGDTF) (“Liberty Gold” or the “Company”) today announces that after more than eight years of distinguished service, Cal Everett, the Company’s Chief Executive Officer and Director, will be retiring from Liberty Gold and will be transitioning to the recently announced spin-out entity, Specialty American Metals Inc., as a non-executive director. The Company’s Board of Directors will appoint Dr. Jon Gilligan as a Board Director as the new President and Chief Executive Officer of Liberty Gold, effective June 12, 2025. Cal will continue to provide his deep expertise in financial...

Continue reading

AirNet Announces Termination of Deposit Agreement

BEIJING, April 28, 2025 (GLOBE NEWSWIRE) — AirNet Technology Inc. (“AirNet” or the “Company”) (Nasdaq: ANTE), today announced that it will terminate the amended and restated Deposit Agreement dated March 29, 2019, among the Company, JPMorgan Chase Bank N.A. (the “Depositary”), and the holders of American depositary shares (the “ADSs”) from time to time, effective May 30, 2025. On or about April 30, 2025, the Depositary of the Company’s American depositary receipts (the “ADRs”), will distribute to all holders and beneficial owners of the Company’s ADRs a notification regarding the termination of ADR facility for the Company’s ADSs pursuant to the Deposit Agreement. The effective date of the termination of the Deposit Agreement will be May 30, 2025 (the “Effective Date”). On the Effective Date, holders of...

Continue reading

Man Group PLC : Form 8.3 – Amendment – American Axle & Manufacturing Holdings Inc

This announcement replaces the previous announcement released at 10:46 25 April 2025. Amendment to section 2(a). All other information remains unchanged. FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: Man Group PLC(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree American Axle & Manufacturing Holdings, Inc.(d)   If an...

Continue reading

Form 8.5 (EPT/RI) – AMENDMENT – Anexo Group Plc

FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)        Name of exempt principal trader: Shore Capital Stockbrokers Ltd(b)        Name of offeror/offeree in relation to whose relevant securities this form relates:         Use a separate form for each offeror/offeree Anexo Group Plc(c)        Name of the party to the offer with which exempt principal trader is connected: Anexo Group Plc(d)        Date dealing undertaken: 24 April 2025(e)        Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer? No2.        DEALINGS BY THE EXEMPT PRINCIPAL TRADER (a)        Purchases and salesClass...

Continue reading

Share repurchase programme: Transactions of week 17 2025

The share repurchase programme runs as from 26 February 2025 and up to and including 30 January 2026 at the latest. In this period, Jyske Bank will acquire shares with a value of up to DKK 2.25 billion, cf. Corporate Announcement No. 3/2025 of 26 February 2025. The share repurchase programme is initiated and structured in compliance with the EU Commission Regulation No. 596/2014 of 16 April 2014, the so-called “Market Abuse Regulation”, and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (together with the Market Abuse Regulation, the “Safe Harbour Rules”). The following transactions have been made under the program:  Number of shares Average purchase price (DKK) Transaction value (DKK)Accumulated, previous announcement 747,686 528.25 394,963,25122 April 2025 17,863 511.44 9,135,78823 April...

Continue reading

Lleida.net increased its sales by 16% in 2024 and recorded profits of €883,000, according to its audited data

Madrid, April 28.- Spanish tech company Lleida.net (BME:LLN) (EPA:ALLN) (OTCQX:LLEIF) increased its sales by 16% during 2024, reaching €19.05 million, according to audited data released today to the market. The company closed the previous year with an audited EBITDA of €3.24 million, representing a significant increase over the €84,000 recorded in 2023. This result confirms the company’s recovery after the losses of 2023. During 2024, the company achieved an audited net profit of €883,000, compared to losses of €2.65 million recorded in 2023. On February 4, 2025, Lleida.net announced its preliminary results to the stock market. Following the audit, the final figures show minor variations from the initial advance, confirming the success of its recovery plan. Lleida.net CEO Sisco Sapena highlighted that “The audited results clearly...

Continue reading

Merck KGaA, Darmstadt, Germany to Acquire SpringWorks Therapeutics to Accelerate Sustainable Growth of Healthcare Business

– Purchase price of $47 per share in cash represents an equity value of approximately $3.9 billion, or an enterprise value of $3.4 billion (€3.0 billion) – – Planned acquisition will immediately add revenue and accelerate mid- to long-term growth for Merck KGaA, Darmstadt, Germany’s Healthcare business – – SpringWorks Therapeutics is a U.S. biopharmaceutical company with a first-in-class, systemic standard-of-care therapy in adults with desmoid tumors and the first and only approved therapy for adults and children with neurofibromatosis type 1-associated plexiform neurofibromas – – Planned acquisition will strengthen the presence of Merck KGaA, Darmstadt, Germany’s Healthcare business in the United States and expand reach of SpringWorks’ therapeutic innovations to more patients with rare tumors worldwide – STAMFORD, Conn., April...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.